相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immunology of neuromyelitis optica: a T cell-B cell collaboration
Meike Mitsdoerffer et al.
TRANSLATIONAL IMMUNOLOGY IN ASIA-OCEANIA (2013)
Vitamin D in Systemic and Organ-Specific Autoimmune Diseases
Nancy Agmon-Levin et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Current Daily Glucocorticoid Use and Serum Creatinine Levels Are Associated With Lower 25(OH) Vitamin D Levels in Thai Patients With Systemic Lupus Erythematosus
Sumapa Chaiamnuay et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2013)
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
Anu Jacob et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus
Ahmed A. Emerah et al.
MOLECULAR BIOLOGY REPORTS (2013)
A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis
Beatriz Pozuelo-Moyano et al.
NEUROEPIDEMIOLOGY (2013)
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
Ilya Ayzenberg et al.
JAMA NEUROLOGY (2013)
Low Serum Vitamin D Levels and Recurrent Inflammatory Spinal Cord Disease
Maureen A. Mealy et al.
ARCHIVES OF NEUROLOGY (2012)
Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor
Iris Navarro-Millan et al.
CLINICAL THERAPEUTICS (2012)
Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics
Kelly C. Simon et al.
CURRENT OPINION IN NEUROLOGY (2012)
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q
C. C. Mok et al.
LUPUS (2012)
Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters
J. Bogaczewicz et al.
LUPUS (2012)
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis
Tessel F. Runia et al.
NEUROLOGY (2012)
Clinical spectrum of CNS aquaporin-4 autoimmunity
S. -H. Kim et al.
NEUROLOGY (2012)
Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder
Eun-suk Kang et al.
ANNALS OF LABORATORY MEDICINE (2012)
Vitamin D Insufficiency in Korea-A Greater Threat to Younger Generation: The Korea National Health and Nutrition Examination Survey (KNHANES) 2008
Han Seok Choi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients
Bianca Weinstock-Guttman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Vitamin D Status and Its Associations with Disease Activity and Severity in African Americans with Recent-onset Rheumatoid Arthritis
Steven M. Craig et al.
JOURNAL OF RHEUMATOLOGY (2010)
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
Akiyuki Uzawa et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability
Maurizio Rossini et al.
ARTHRITIS RESEARCH & THERAPY (2010)
The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis
Joost Smolders et al.
AUTOIMMUNITY REVIEWS (2009)
Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
Joost Smolders et al.
PLOS ONE (2009)
Aquaporin-4 antibodies in neuromyelitis Optica and longitudinally extensive transverse myelitis
Patrick Waters et al.
ARCHIVES OF NEUROLOGY (2008)
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
J. Smolders et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Vitamin D deficiency in undifferentiated connective tissue disease
Eva Zold et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation
Sheng Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
I. A. F. van der Mei et al.
JOURNAL OF NEUROLOGY (2007)
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
Shanu F. Roemer et al.
BRAIN (2007)
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
T. Misu et al.
BRAIN (2007)
Neuromyelitis optica: New findings on pathogenesis
Dean M. Wingerchuk
NEUROBIOLOGY OF MULTIPLE SCLEROSIS (2007)
The spectrum of neuromyelitis optica
Dean M. Wingerchuk et al.
LANCET NEUROLOGY (2007)
Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-Cell function and FOXP3 expression
Koen Venken et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Vitamin D deficiency in systemic lupus erythematosus
DL Kamen et al.
AUTOIMMUNITY REVIEWS (2006)
25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis
M Soilu-Hänninen et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus
JB Zella et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2003)
1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells
A Boonstra et al.
JOURNAL OF IMMUNOLOGY (2001)
Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance
S Gregori et al.
JOURNAL OF IMMUNOLOGY (2001)